0001654954-24-001967.txt : 20240220 0001654954-24-001967.hdr.sgml : 20240220 20240220161116 ACCESSION NUMBER: 0001654954-24-001967 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: lee ting-chuan CENTRAL INDEX KEY: 0001859311 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41461 FILM NUMBER: 24653387 MAIL ADDRESS: STREET 1: 8880 RIO SAN DIEGO DRIVE STREET 2: SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ainos, Inc. CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 BUSINESS PHONE: 858-869-2986 MAIL ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 FORMER COMPANY: FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC DATE OF NAME CHANGE: 19960516 4 1 section16.xml PRIMARY DOCUMENT X0508 4 2024-02-16 0001014763 Ainos, Inc. AIMD 0001859311 lee ting-chuan 8880RIOSANDIEGODRIVE, SUITE800 SANDIEGO CA 92108 true false CommonStock 2024-02-16 4 A false 14400 0.8693 A 80831 D RSU 2024-02-16 4 C false 14400 D CommonStock 14400 101200 D Reference is made to (i) 480,000 RSUs that were granted on August 15, 2023, adjusted to 96,000 shares giving effect to the 1 for 5 reverse share split on December 14, 2023, pursuant to the Company's 2023 Stock Incentive Plan, with vesting occurringin increments of 15% on 2/15/24, 15% on 8/15/24,30% on 8/15/25, and 40% on 8/15/26 subject to normal and customary termination events; and (ii) 70,000 RSUs granted under the 2021 Stock Incentive Plan, as amended by the 2023 Stock Incentive Plan, adjusted to 14,000 shares giving effect to the 1 for 5 reverse share split on December 14, 2023, with vesting occurring in increments of 2,100 shares on 5/14/23 and 11/14/23, respectively, 4,200shares on 11/14/24 and 5,600 shares on 11/14/25, subject to normal and customary termination events. /s/ Chun-Hsien Tsai per POA for Lee, Ting-Chuan 2024-02-20